Monday, 16 October 2017

Lab-On-a-Chip Market by product type, and end-user - Global Industry Insights, Size, Share, Trends, 2025

A lab-on-a-chip (LOC) is a device that incorporates one or several laboratory functions on a single integrated circuit whose size varies from few millimeters to limited square centimeters to achieve automation and throughput screening process. Lab-on-a-chip devices can hold up to a small amount of fluid having volume less than Pico liters. Furthermore, such devices are the part of micro electro mechanical systems (MEMS), which is also known as micro total analysis system (┬ÁTAS). Lab-on-a-chip devices allow laboratory synthesis or chemical analysis on a very small scale that have recently shown significant benefits and potential for a wide range of applications such as genomic research, proteomics research, analytical chemistry, environmental monitoring, the point of care diagnostics, and biohazards detection. LOC devices reduces the use of reagents and sample consumption, which reduces the result output time. LOC devices are small in size, portable, cost effective in manufacturing and requires less power as compared to conventional lab devices. These are the few factors, which are expected to fuel the growth of the lab-on-a-chip market.

Tailored Information as per niche requirement: https://www.coherentmarketinsights.com/insight/request-sample/515

Lab-on-a-chip market taxonomy:

By Application
  • Genomics
  • Proteomics
  • Diagnostics
  • Drug Discovery
By Product
  • Reagents and Consumables
  • Software
  • Instruments
By End-User
  • Hospitals
  • Diagnostic Labs
  • Academic and Research Institutes
  • Home Care
  • Biotechnology and Pharmaceutical Companies
By Technology
  • Microarrays
  • Microfluidics
Wide range of application and advance technology fuels the growth of lab-on-a-chip market

Lab-on-a-chip devices are used for various purposes such as analytical chemistry and diagnostics but they are majorly used in diagnostic and life-science research. The utilization of the device is significantly depends on the epidemiological factors globally. For instance, there is an increase in infectious diseases such as HIV, tuberculosis, measles and malaria. As per The Joint United Nations Programme on HIV/AIDS (UNAIDS) there are around 36 million people infected from HIV/AIDS globally. Also, there is observable rise in peripheral vascular disorders such as claudication, arteriosclerosis obliterans and intermittent claudication. Furthermore, with an increase in healthcare investment the market growth of LOC devices is expected to gain traction in the near future.

In 2016, according to Centers for Disease Control and Prevention (CDC), in the U.S. 12-20% of the population aged age 60 and above are diagnosed with the peripheral vascular disease every year, which is approximately 8.5 million. There is a significant increase in geriatric population that supports the growth in lab-on-a-chip market as according to World Health Organization (W.H.O) it is expected that in near future geriatric population will double. According to National Institute of Aging, in 2016 there are around 620 million people globally are above the age of 65 and is expected to grow to 1.6 billion by 2050. Moreover, the increase in personalized medicine and cancer research will lead to the increase in the lab-on-a-chip market in the near future with many of the further supporting factors of the devices such as user friendly approach, easily portable and wide use in hospitals and surgical centers supports. Increasing use of conventional laboratory equipment is the major challenge that is expected to slow down the pace in awareness of the device by healthcare experts. Lab-on-a-chip technology is projected to get commercialized gradually however, in near future, this technology is expected to play a major role in the life-science industry.


Developed regions are major growth engine of lab-on-a-chip market

The globally lab-on-a-chip market is segmented into North America. Latin America, Europe, Asia-Pacific, Middle East and Africa. North America is leading the market in terms of increase in geriatric population, research, advancement in technology and wide acceptance of the lab-on-a-chip technology. According to Population Reference Bureau, in 2016 there were around 40 million people in U.S. above 65 and over and it is expected to reach 19 million by 2050. Europe is the second largest region in the lab-on-a-chip market due to the region being an early adopter of advanced technologies. Asia Pacific is the fastest emerging region due to a large population and unmet clinical needs of people. According to Economic and Social Commission for Asia and the Pacific, in 2016, there are around 4.5 billion people in Asia Pacific.

Key players to support the growth of lab-on-a-chip market

Takra Bio Inc., Nobel Biocare Services AG, Bio-Rad Laboratories Inc., PerkinElmer Inc., and Cepheid Inc., are among the major players in the lab-on-a-chip market.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Saturday, 14 October 2017

Insulin Pumps Market by product type, and end-user - Global Industry Insights, Size, Share, Trends, 2025

Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin is delivered continuously whole day for maintaining normal function of body that is programmed by health care professionals and as bolus dose, which is the additional dose of insulin required according to the food supply to correct the blood sugar level of the body. Insulin pump consists of main pump unit that holds insulin reservoir i.e. 176-300 units of insulin. There are various types of insulin used to treat diabetes that includes rapid, short, intermediate and long acting insulin.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/416

The essential factors driving the growth of this market is diabetes, awareness of diabetes, type of insulin and different methods to deliver insulin. Insulin pump device are small and durable. Insulin pumps are user friendly, as they can be programmed easily and LCD screen is available for display of programs. Battery compartment and reservoir compartment is also compact. Insulin pump provides more flexibility to lifestyle as it is highly portable. Number of injection are also reduced due insulin pumps. Whereas there is precise delivery of insulin to gain better control on diabetes.

Insulin pump market taxonomy
Product Type
  • Traditional insulin pumps
  • Disposable insulin pumps
  • Smart pumps
End Users
  • Hospital
  • Clinics
  • Home Care
  • Laboratories
Rising number of diabetes to fuel the growth of insulin pump market in the near future:

According to Lancet study 2016, there was four fold increase in number of diabetes 108 million in 1980 to 422 million in 2014 and half of them live in India, China, U.S., Brazil, and Indonesia. Rise in number of diabetic patient globally is expected to favor growth of the insulin pump market in the near future. There are two types of diabetes type 1 and type 2. In type 1 diabetes, immune systems destroys the cells in pancreas called as beta cells which are responsible for insulin production. So externally manufactured insulin needs to be provided by insulin pump to recover a person from diabetes which in turn is expected to favor the insulin pump market in the near future. In type 2 diabetes body does not use insulin properly it is also called as insulin resistance. So type 2 diabetes patient need to take multiple shots of insulin which is provided by insulin pump as it is designed to deliver continuous amount of insulin 24 hrs. According to findings of various studies in 2015, insulin pump is a safe and valuable treatment option for diabetes. Other advantage of the insulin pump is that it frees you from having to measure insulin into a syringe. According to WHO the number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014.  Which is further projects to favor growth of the insulin pump market in the near future. The above reasons are projected to provide significant traction in the growth of insulin pump market over the forecast period.


Diabetes prevalence has been rising more rapidly in middle- and low-income countries that is expected to support the growth in insulin pumps market

The International Diabetes Federation estimated that 8.3% (382 million) of adults globally had diabetes in 2013 and that the prevalence vary across different countries.  According to American diabetes Association age- and sex-adjusted diabetes prevalence were highest in the poorer countries and lowest in the wealthiest countries. LIC (Bangladesh, India, Pakistan, and Zimbabwe) 14.0%, LMIC (China, Colombia, and Iran, Palestine) 10.1%, UMIC (Argentina, Brazil, Chile, Malaysia, Poland, South Africa, and Turkey) 10.9%, and HIC (Canada, Sweden, and the United Arab Emirates) 5.6% Differences between countries may be the because of differences in the distributions of risk factors among countries, such as family history of diabetes, age, obesity, socioeconomic status, birth weight,  ethnicity, and the degree of westernization. This augments growth of the insulin pump market more in middle- and low-income countries.

Major acquisitions to support growth of insulin pump market.

Medtronic Integrated performance report sales increased from US$15,000 in 20212 to US$ 30,000 in 2016. Key players operating in insulin pump market include Medtronics, Braun Melsungen Abbott Laboratories, Becton, Dickinson and Company, Sanofi, Insulet Corporation, and Hoffmann-La Roche AG.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Friday, 13 October 2017

Bronchoscopes Market by product type, application, end-user - Trends, Outlook, and Opportunity Analysis, 2017–2025

Bronchoscopes is an endoscopic technique used for diagnostic and therapeutic process to study the inner pathways of lungs. Bronchoscopes are the devices that are introduced from the mouth or nose and occasionally through tracheostomy to observe distal branches of the bronchi. Furthermore, bronchoscopes are commonly used to diagnose tumors, infection, inflammation, foreign bodies, lung bleeding, and parasites. Bronchoscopes are classified into two forms named as rigid and flexible on the basis of their designs. Rigid bronchoscopes employ metal parts, which allows them to remove foreign bodies while flexible bronchoscopes design allow greater entrance as they employ flexible optical cables that enables real time video recording. The flexible bronchoscope flexibility tends till 180 degree allowing great maneuverability. However, depending upon the nature of medical conditions, major types of bronchoscopes have their respective advantages.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/421

Medical conditions where support is required, rigid designed bronchoscope were used for example tracheal wall collapses, aspiration, removal of foreign body, electron cauterization and so on. On the other hand rigid bronchoscopes are more prone to cause tissue damage and also side effects like damaged vocal cord systems, pneumothorax and others. Flexible bronchoscopes can reach easily to deep alveoli sacs medical conditions such as biopsy, suctioning, laser resection of tumors, cauterization can be performed using flexible bronchoscopes. Cost wise, rigid bronchoscopes are much competent to flexible versions as flexible bronchoscopes are high in cost however they are in significant use due to its better efficiency in terms of applicability and versatility.

Bronchoscopes market taxonomy:

By Product Type
  • Rigid Bronchoscopes
  • Flexible Bronchoscopes
By application
  • Bronchial diagnosis
  • Bronchial treatment
By End User
  • Hospitals & Clinics
  • Ambulatory Surgical Centers (ASCs)
Bronchoscopes devices is being fuelled by rising incidence of diseases

Bronchoscopes is a valuable tool for evaluation and management of airway disease. It is used to evaluate various bronchopulmonary diseases including tumors, chronic obstructive pulmonary diseases, airway foreign bodies, bronchopulmonary hemorrhage, and airway stenosis, infectious and inflammatory conditions. Bronchoscopes can be used to find the cause of airway problems, such as airway bleeding, trouble in breathing, or a long-term cough. Blockage created in the airway or narrowed airways can also be removed using bronchoscopes. Bronchoscopes are used to treat cancer of the airway using radioactive materials. Bronchoscopes are also used to take tissue sample when other tests, such as CT scan or X-ray show problem with lung or with lymph nodes in chest. Lung diseases such as chronic obstructive pulmonary diseases (COPD) sinusitis and otitis media are diagnosed by collecting tissue or mucus samples for examination the extent of diseases is also analyzed using bronchoscopes. According to WHO, it is estimated that around 3 million deaths were reported worldwide due to COPD in 2015.

Growth engines for bronchoscopes market

Most populated and urbanized regions such as North America, Asia pacific and European region in world that uses the medical advances for treatment purpose shows the largest bronchoscopes market. The high growth in India and China can be attributed to government and venture capital investments in China in the field of bronchoscopes, bronchoscopes research support in Japan (WABIP), and increasing number of bronchoscopes surgeries & improving bronchoscopes infrastructure in India. According to Centers for Disease Control and Prevention (CDC) 212,584 people in the U.S. were diagnosed with lung cancer in 2013. Furthermore, W.H.O shows highest lung cancer mortality rate (per 10,000) in 2012 were 47.6 in Central and Eastern Europe which augments growth of the bronchoscopes market.


Major acquisitions to support growth of bronchoscopes market

The World Association for Bronchology and Interventional Pulmonology (WABIP) organization consists of over 7,200 medical professionals representing over 50 regional professional representation and national societies that is expected to favor growth of bronchoscopes market. Key players operating in bronchoscopes market include Olympus Corporation, Fujifilm Holdings Corporation, and PENTAX Medical Company. 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Thursday, 12 October 2017

Balloon Catheters Market, By, Geography - Opportunity Analysis, and Industry Forecast till 2025

The balloon catheter is a flexible, tubular device with a balloon at its tip that is used to create, enlarge or remove blockage of a passageway within the body, by passing it through body channels. The balloon tip can be expanded by water or air to remove the blockage or to expand partly closed passageway during procedure. The balloon catheter used to treat heart related disease specifically coronary heart disease, which are caused due to diabetes, high blood pressure and high cholesterol level in blood. During the treatment of coronary heart disease, the balloon catheter helps to allow the blood flow from arteries by making a passageway that is blocked due to excess cholesterol by avoiding open heart surgery.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/489

Also, the balloon catheter plays major role in angioplasty to treat atherosclerosis by widening the narrowed or obstructed arteries or veins. As, the procedure is minimally invasive, it is economically beneficial to the patient and helps patient to get cure rapidly as compared to open surgical procedure.

Market Dynamics

Rising incidence of cardiovascular disease and coronary heart disease cases due to increase in the prevalence of diabetes, high blood pressure cases and number of smokers worldwide is expected to favor the demand for balloon catheters around the globe.

According to World Health Organization (WHO), in 2015 around 17.7 million people died due to cardiovascular disease worldwide, and out of this total deaths around 7.4 million were die due to coronary heart disease. Furthermore, the majority of deaths are occurred in emerging economies due to high prevalence rate and lack of healthcare services in rural areas.

Also, increasing aging population and rising demand for minimally invasive procedures are the other factors leading to the growth of balloon catheters market in developed as well as emerging economies.

As per United Nations Population Fund, people aged 60 years and above accounted for 12.3% of the global population in 2015, which is expected to increase to 22% by 2050. The factors behind aging population in developed region are developed healthcare services and access of healthcare facilities to people, better nutrition, sanitation and economic development.


Market Taxonomy

This report segments the global balloon catheters market on the basis of product material and geography. On the basis of material, the market is categorized into polyurethane, nylon and other type of materials such as pebax. Among these, the polyurethane segment dominate the balloon catheters market throughout the forecast period. On the basis of geography, the market is divided into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Among all regions, North America contributes major market share supported by increased incidence rate of cardiovascular disease and growing inclination of the populace towards minimally invasive procedures.

Key features of the study:
  • This report provides in-depth analysis of the balloon catheter market and provides market size (US$ Mn) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2017–2025)
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, pipeline products, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global balloon catheter market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future product launch, market expansion, and marketing tactics
  • The global balloon catheters market report caters to various stakeholders in this industry, including investors, product developers, distributors, healthcare companies, research institutes, medical device companies, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision making through the various strategy matrices used in analyzing the balloon catheters market
About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Wednesday, 11 October 2017

Small Cell Lung Cancer Therapeutics Market on the basis of diagnosis, types, treatment, drug therapy, and end user - Global Industry Insights, 2025

Small Cell Lung Cancer (SCLC) is malignant form of cancer arising within the lungs. SCLC is characterized by high growth rate, shorter doubling time than the non-small cell lung tumors. SCLC is more responsive to chemotherapy than NSCLC. Small cell lung cancer is highly associated with tobacco, unhealthy food, alcohol, HIV infected, chronic infections or related family history, and physical inactivity. The decrease in smoking is reflected as the substantial decrease in the incidence of SCLC. The symptoms include dyspnea, blood in sputum, weight loss, cough, and debility.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/799

Global rise in number of cancer cases expected to support the growth of small cell lung cancer therapeutics market in the near future

According to the American Cancer Society Statistics in 2016, maximum cases of SCLC occur in individuals aged 60-80 years with an estimated global death rate being 30,000 per year. Also, according to the World Health Organization (WHO), lung cancer is the second most prevailing cancer in men and women causing 1.59 million deaths in 2012. The rising prevalence of lung cancer, rise in unhealthy lifestyle, the launch of innovative radiation therapies, and premium priced drugs are the major factors driving the growth of lung cancer therapeutics market. Additionally, rising demand for targeted therapies and platinum-based chemotherapies is likely to have an optimistic impact on the small lung cancer therapeutics market in the forecast period. Also, increasing diagnostic facilities by the government, provision of guidelines to cancer patients by International Healthcare Organizations are the major factors contributing to the rising of small cell lung cancer market. However, expensive treatments, lack of awareness leading to late diagnosis are the major factors restraining the small cell lung cancer market growth.

Platinum derivatives segment accounts for highest revenue share owing to the higher metastasis control rate

The global small cell lung cancer therapeutics market is segmented on the basis of diagnosis, types, treatment, drug therapy, and end user.

On the basis of diagnosis, the global small cell lung cancer therapeutics market is segmented into:
  • Fluorescence Bronchoscopy
  • Virtual Bronchoscopy
On the basis of types, the global small cell lung cancer therapeutics market is segmented into:
  • Oat cancer
  • Combined small cell cancer
  • Extrapulmonary small cell cancer
On the basis of treatment, the global small cell lung cancer therapeutics market is segmented into:
  • Real-time Tumor Imaging
  • Radiation Therapy
  • Three-dimensional conformal radiation therapy (3D-CRT)
  • Intensity modulatedradiation therapy (IMRT)
  • Chemotherapy
  • Platinum Derivatives
  • Topoisomerase Inhibitor
  • Surgery

On the basis of drug therapy, the global small cell lung cancer therapeutics market is segmented into:
  • Targeted Therapy Drugs
  • Immunotherapy Drugs
On the basis of end user, the global small cell lung cancer therapeutics market is segmented into:
  • Hospital
  • Hospital Pharmacies
  • Drug store
  • Ambulatory Surgical Center
Enhanced health care dynamics to boost the Asia Pacific small cell lung cancer market

Regional segmentation of small cell lung cancer therapeutics market by Coherent Market Insights comprises of North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. According to the American Cancer Society Statistics in 2017, around 222,500 cases of lung cancer were diagnosed with 116,990 prevailing in men and 105,510 in women, where small cell lung cancer accounts for 15 percent of lung cancers in the U.S. North America is expected to dominate the market owing to the high developed regions, improved healthcare setup, and growing awareness about healthcare. Asia Pacific is expected to drive the growth of SCLC market in the forecast period owing to the growing awareness of health care, government funding, and the presence of medical requirements for cancer therapeutics in the emerging economies such as India and China.


Key players in the Small Cell Lung Cancer Therapeutics Market

Key players operating the small cell lung cancer therapeutics market include Elekta AB, Bristol Myers Co., Teva parenteral medicines Inc., Siemens Healthcare GmbH, App pharmaceuticals llc Novartis AG, and Bedford laboratories. 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Tuesday, 10 October 2017

mHealth Market on the basis of equipment, service, therapeutics and geography - Global Industry Insights, Trends, 2025

mHealth stands for mobile health is the sub segment of eHealth that deals with the medicinal practice in favor of public health care, supported by mobile devices. The term mHealth is used to refer the use of mobile communication devices such as mobile phones, electronic tablets, PDAs and also comprises of wearable devices such as a smart watch for data collection and information about health care services. mHealth is applicable in wide areas, ranging from collection of community and clinical health data and delivery of healthcare information to medical personnel to real time monitoring of the patient by provision of direct care. In developed countries the patients and consumers extensively use mobile gadgets to search for healthcare services and access various kinds of healthcare information. Doctors, physicians and even nurses are found making use of mobile devices to access information about a patient from established databases and other resources. The mHealth market comprises of devices such as ECG monitors, blood glucose meters, multi parameter trackers, sleep apnea trackers, etc.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/749

Robust penetration of smartphones in the developed as well as developing countries responsible to boost global mHealth market

According to World Health Organization (WHO), 112 member states participated in the module of survey, out of which 83% were reported to possess at least one mHealth initiative in their country. A majority of these member states reported implementation of 4 or more types of mHealth initiatives. As per the mHealthShare factsheet, 62% of smartphone owners in the U.S. have used their phone in 2014 to look up for health condition and information as compared to that of 52% in 2012. The rising interest and extensive use of mobile devices including tablets are widening the scope of global mHealth market.

The global mHealth market is segmented on the basis of equipment, service, therapeutics and geography.

On the basis of equipment, the global mHealth market is segmented as
  • Blood Glucose Meters
  • BP Monitors
  • Pulse Oximeters
  • Neurological Monitoring
  • Cardiac Monitors
  • Apnea and Sleep Monitor
  • Wearable fitness sensor device and Heart Rate Meters
  • Others
Based on the service type, the global mHealth market is segmented as
  • Wellness Service Market
  • Prevention Services Market
  • Treatment Services Market
  • Diagnosis Service Market
  • Monitoring Services Market
  • Healthcare Systems Strengthening Solutions Market
Based on the therapeutic segment, the global mHealth market is segmented as
  • Cardiovascular
  • Diabetes
  • Respiratory
  • Neurology
  • Others
Asia Pacific is expected to show an accelerating global mhealth market mainly due to government initiatives in spreading healthcare awareness

On the basis of geography, the global mHealth market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East and Africa. The mHealth market is spurred in the North America attributing to flourishing number of pilot projects and live health in the U.S. and Canada. The increase in number of wellness apps coupled with rising adoption of smartphones as well as increasing reliability on mobile phone apps for day to day routine is expected to accelerate the regional market in the coming forecast years. Further, rise in the rural population in countries such as Vietnam, Indonesia and India are also diligently involved in expansion of global mHealth market. Certain solutions such as bulk messaging to inform disease spread and awareness tips are commonly used in these countries. Use of local language to compose these text messages effectively helps in delivering the information to the rural population. Indian government has launched an official application named National Health Portal, India that is designed in a way to provide access and information about healthcare to a predominantly semi- literate or illiterate population.


Factors responsible to boost the mHealth market involves rising awareness among people regarding regular health updates

The primary factor responsible to drive the global mHealth market is the affordability and integration of wireless technologies which can cause a breakthrough in monitoring and diagnostics, mainly in the developing countries where smartphones are penetrating the market at a great speed. The rapid rise in the incidence of the chronic diseases as well as the advancing technologies in the mobile health apps that delivers information of personal healthcare on the regular basis are also responsible to fuel mHealth market. For instance, the in- build health app in the Apple phones provides insights about the activity, sleep, nutrition, everyday workout and even maintains reproductive health acting a smart assistant for the mobile phone users. Moreover, the mHealth devices such as glucometers and oximeters are applicable in the geriatric population of monitoring blood glucose levels and oxygen levels mainly in the diabetic population. However, lack of accuracy of these devices could restrain the market growth as many people complain about the extreme results displayed by these devices.

The key players involved in improvement of the mHealth devices to increase sales in the global mHealth market

The key players operating the mHealth market are Medtronic Inc., Apple Inc., Sanofi, Mobistante, Inc., AirStrip Technologies, Inc., AliveCor, Inc., LifeWatch AG, Koninklijke Philips N.V, Jawbone, Nike, Inc., Omron Corporation, Johnson and Johnson, Bio Telemetry Inc., Withings, AgaMatrix Inc., iHealth Lab Inc., Qualcomm, AT&T, Cerner Corporation and Cisco Inc. The mobile service provider companies are focusing to deliver uninterrupted healthcare services in the robust penetration of 3G and 4G networks across the world while several other companies manufacturing healthcare related technological devices are focusing towards providing devices with more precision and accuracy to the users by better optimization and improving the sensitivity of these devices.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Monday, 9 October 2017

Computed Tomography Market by product type, application, and end-user - Opportunity Analysis, 2025

Computed Tomography (CT), also called computed axial tomography or computerized tomography, is an imaging technique that uses combinations of various X-ray images taken from different angles that produces cross-sectional images of specific internal body organs. CT images can be used for various diagnostic, research and therapeutic purposes. Computed tomography is mainly used for detect to diagnose differences in circulatory system diseases and conditions such as blood vessel aneurysm, kidney stones, blood clots, brain and head injuries, infarction, calcification, tumors, hemorrhage, internal bleeding and uncontrolled and abnormal cell growth in cancer patients. CT is advantageous over conventional 2D radiography in several ways as the images produced by CT totally eliminates the superimposition of images that are outside the area of interest. Moreover, the CT produces high resolution images that can easily differentiate between tissues that are different in their physical intensities.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/495

Increase in prevalence of cancer and orthopedic disorders to boost growth of the global computed tomography market

According to American Cancer Society, around 1.7 million new cases of cancer were diagnosed in the U.S. in 2015, resulting in 589,430 fatalities. This high death rate could be lowered with the use of early detection and better diagnostic systems. Thus, computed tomography providing better diagnostic solutions to detect abnormal cell growth and tumors in the body is expected to show a market rise in the forecast period. Additionally, according to the World Health Organization (WHO), on an average 17.7 million people across the globe died due to cardiovascular disorders in 2015. This inadvertently creates a highly conducive environment for growth of the global computed tomography market.

The global computed tomography market can be segmented on the basis of product type, application, end user and geographical region.

On the basis of product type,
  • Low Slice CT Scanner (<64 slices)
  • Medium Slice CT Scanner (64 slices)
  • High Slice CT Scanner (>64 slices)
On the basis of application,
  • Cardiovascular Application
  • Oncology
  • Neurovascular Application
  • Abdomen and Pelvic Application
  • Pulmonary Angiogram
  • Spinal Application
  • Musculoskeletal Application
Based on the end user,
  • Diagnostic centers
  • Hospitals
  • Others
North America to dominate the global computed tomography market, owing to increased

On the basis of regional segmentation, the global computed tomography market can be segmented into North America, Latin America, Europe, Asia Pacific, Middle East and Africa. North America dominates the global computed tomography market owing to high spending power of the companies to come up with innovative features in the field of medical imaging as well as technological advancement. Europe and Asia Pacific are expected to exhibit rapid growth in the global computed tomography market, due to upcoming government policies and presence of various major players in the region. For instance, the U.S. FDA recently in 2017 passed a regulatory guideline which states initiative to reduce unnecessary radiation exposure from medical imaging in order to manage the risks of computed tomography (CT), fluoroscopy and nuclear medicine imaging procedures.


The increase in demand and popularity for high quality health care solutions are driving the global computed tomography market

Along with high prevalence and incidence rates of cancer and cardiovascular diseases, the prevalence rate of musculoskeletal and orthopedic disorders are also responsible to drive the global computed tomography market. A report by Science Daily suggested that 126.6 million Americans i.e. one in two adults in America is affected by some or the other musculoskeletal disorders. This suggests that the global market can be potentially driven by a large number of patients suffering from musculoskeletal disorders for the diagnosis of the malfunction and treatment pain inducing areas. In addition to this, several other factors driving the global computed tomography market includes rise in global geriatric population, growing public awareness and technological advancements in health care. However, the side effects caused due to the radiations could obstruct the market from propelling.

The key players in the global computed tomography market include GR Healthcare, Siemens Healthcare, Toshiba Medical System Corporation, Philips Health Care, Hitachi Medical Corporation, Neurologica Company Ltd., and Neusoft Medicals. Improvement in the non-invasive techniques for medical diagnostic imaging facilities and employment of strategies such as partnership, merger and acquisition are helping these companies to grab a major share in the global computed tomography market.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.